The development of novel therapeutics offers great hope for the fight against widespread diseases such as cancer, but they can impair the cardiovascular system, so development often fails early on.

A sweeping single-nucleus atlas reveals how human hearts lose cellular balance with age and points to PRDM16 as a potential molecular target for future cardiac aging research. Study: ...

Researchers at The University of Osaka have reported that simultaneous delivery of five therapeutic messenger RNAs reduced heart tissue damage, improved cardiac function and increased survival in ...